MicroRNA-128 promotes apoptosis in lung cancer by directly targeting NIMA-related kinase 2

Area of Science:

• Molecular Biology
• Oncology
• Gene Regulation

Background:

• MicroRNA-128 (miR-128) is a known regulator of cancer cell apoptosis, differentiation, epithelial-to-mesenchymal transition, and tumor growth.
• NIMA-related kinase 2 (NEK2) is frequently overexpressed in lung cancer.
• The prognostic significance of the miR-128/NEK2 pathway in colorectal cancer is established, but its role in lung cancer remains unclear.

Purpose of the Study:

• To investigate the association between miR-128 and NEK2 in lung cancer.
• To determine if miR-128 regulates NEK2 expression in lung cancer cells.
• To elucidate the role of the miR-128/NEK2 axis in lung cancer cell apoptosis.

Main Methods:

• Quantitative real-time PCR (qRT-PCR) and Western blot were used to assess miR-128 and NEK2 expression levels in lung cancer tissues and cell lines.
• Lung cancer cells (SK-MES-1) were transfected with miR-128 mimics or inhibitors.
• Apoptosis was analyzed using flow cytometry, and direct interaction between miR-128 and NEK2 was confirmed via dual-luciferase assays.

Main Results:

• miR-128 was significantly downregulated, while NEK2 was upregulated in lung cancer tissues compared to adjacent non-tumor tissues.
• Transfection with miR-128 mimic increased apoptosis in lung cancer cells and decreased NEK2 protein levels, whereas a miR-128 inhibitor had the opposite effect.
• Dual-luciferase assays confirmed NEK2 as a direct target of miR-128. Overexpression of NEK2 reversed the apoptotic effect induced by miR-128 mimic.

Conclusions:

• NEK2 expression is directly regulated by miR-128 in lung cancer.
• miR-128 induces apoptosis in lung cancer cells by modulating NEK2 expression.
• The miR-128/NEK2 pathway represents a potential therapeutic target for lung cancer.